You searched for "ERS"

763 results found

Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL

Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...

Use of automated audiometry for faster patient access to audiology services?

Manual audiometry has long been the gold standard for establishing hearing thresholds. In recent years, a number of automated audiometry applications have reached the market. In this article, a team from Ireland have put a version of automated audiometry to...

Does the overuse of noise-cancelling headphones cause APD?

Have you heard the noise around APD? With a flurry of interest around noise-cancellation and APD, Dale Hewitt offers his take on the evidence and theory. When and why did this question first arise? An article was published by BBC...

New TympStar Pro updates including WideBand tympanometry

Grason-Stadler, a worldwide leader of clinical audiometric systems, is pleased to announce new updates to their leading clinical tympanometer, the GSI TympStar Pro™.

Lenire®, the tinnitus treatment device, now available in Norway

Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

Neuromod advances multiple regulatory approvals to expedite Lenire’s global availability

Neuromod, the medical technology company that created the Lenire® tinnitus treatment device, has announced approval to the Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification. Neuromod’s MDSAP certification follows a comprehensive audit verifying compliance with...

Achieving consensus on candidacy for cochlear implantation

The British Cochlear Implant Group’s candidacy working group recently ran a national exercise, working towards a consensus on candidacy for cochlear implantation in the UK. Padraig Kitterick and Debi Vickers were instrumental in this exercise, and in the article below,...

Beyond blocked noses: paediatric olfactory dysfunction for the ENT surgeon

Smell loss in children often goes unnoticed. Recognising the signs, understanding the causes and improving access to assessment could transform care. The hidden epidemic: why smell matters in children When a child presents with nasal obstruction, we instinctively look for...

Human factors, theatre ethnographics and Girls Aloud

The issue of ambient music in the operating theatre is frequently controversial and has been known to cause ‘Bluetooth wars’, as different team members vie for control of the speakers. Our own Chris Potter gives his personal slant on this...

GIRFT: improving ENT care through standardised clinical pathways

Clinical pathways can help to ensure consistency of approach and efficient use of resources. We hear about new developments in the UK. Variation in ENT care In today’s data-driven healthcare landscape, significant variation persists in the provision of ENT services...

Hearing aid outcomes in older adults: what and when to measure

What matters to older adults when purchasing a hearing aid? Larry Humes explores the domains that should be measured for this key group. This article identifies key domains of hearing aid outcome in older adults. Increasingly, third-party payers and private-pay...